Sutton Wealth Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Sutton Wealth Advisors's NVS Position: Q2 2023 in Review
Sutton Wealth Advisors sold out of Novartis (NVS) in Q2 2023, closing a stake of 53 shares — an estimated $4.88K sold.
Sutton Wealth Advisors first reported a position in NVS in Q1 2016 and held it in 29 quarters. The position peaked at $176K in Q4 2022. 1,203 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Sutton Wealth Advisors reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
- Sutton Wealth Advisors sold 53 Novartis shares in Q2 2023, an estimated $4.88K.
- Sutton Wealth Advisors first reported a position in Novartis in Q1 2016 and held it in 29 quarters.
- Sutton Wealth Advisors's Novartis position peaked at $176K in Q4 2022.
- 1,203 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Sutton Wealth Advisors's 13F filing for Q2 2023, filed 8 Nov 2023.